United States of America Continuous Glucose Monitoring Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (undefined)

United States of America Continuous Glucose Monitoring Market is Segmented By Components (Sensors, Transmitters & Receivers, Integrated System, Others), By Demographic (Adults (18-65), Geriatrics (65+), Pediatrics/ Teenagers), By Indication (Type 1 Diabetes, Gestational Diabetes, Type 2 Diabetes, Others), By End-User (Hospitals, Home Care, Clinics, Nursing Homes, Others). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States of America Continuous Glucose Monitoring Market

The major players operating in the United States of America Continuous Glucose Monitoring Market include Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., F. Hoffmann-La Roche Ltd., GLUCOVATION, INC., Nemaura Medical Inc., GlySens, GlucoModicum, and Signos, Inc.

United States of America Continuous Glucose Monitoring Market Leaders

  • Abbott
  • Dexcom, Inc.
  • Medtronic
  • Senseonics, Inc.
  • F. Hoffmann-La Roche Ltd.
*Disclaimer: Major players are listed in no particular order.

United States of America Continuous Glucose Monitoring Market - Competitive Rivalry, 2023

Market Concentration Graph

United States of America Continuous Glucose Monitoring Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights